Faster-acting insulin aspart provides faster onset and greater early exposure vs insulin aspart in children and adolescents with type 1 diabetes mellitus
Author:
Affiliation:
1. Diabetes Centre for Children and Adolescents; Kinder- und Jugendkrankenhaus AUF DER BULT; Hannover Germany
2. Biostatistics; Novo Nordisk A/S; Søborg Denmark
3. Clinical Pharmacology; Novo Nordisk A/S; Søborg Denmark
Funder
Novo Nordisk
Boehringer Ingelheim
Medtronic
Sanofi
Publisher
Wiley
Subject
Endocrinology, Diabetes and Metabolism,Pediatrics, Perinatology and Child Health,Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/pedi.12506/fullpdf
Reference27 articles.
1. Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines;Wood;Diabetes Care,2013
2. Type 1 diabetes through the life span: a position statement of the American Diabetes Association;Chiang;Diabetes Care,2014
3. Assessment and monitoring of glycemic control in children and adolescents with diabetes;Rewers;Pediatr Diabetes,2014
4. Decrease in clinical hypoglycemia in young children with type 1 diabetes treated with free-mixed aspart and detemir insulin: an open labelled randomized trial;Petit-Bibal;Pediatr Diabetes,2015
5. ISPAD Clinical Practice Consensus Guidelines 2014. Insulin treatment in children and adolescents with diabetes;Danne;Pediatr Diabetes,2014
Cited by 57 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Ultrafast-acting insulin: pharmacological properties and their impact on clinical aspects;Meditsinskiy sovet = Medical Council;2024-09-02
2. Clinical practice recommendations for management of Diabetes Mellitus in Arab region: An expert consensus statement from Arab Diabetes Forum (ADF);Primary Care Diabetes;2024-07
3. Results of biosimilar assessing of insulin aspart preparations of Russian and foreign production using the hyperinsulinemic euglycemic clamp method and studying the use of a new ultra-fast-acting Russian biosimilar in pumps;Meditsinskiy sovet = Medical Council;2024-02-26
4. Factors affecting the prolongation of glycemic time in range among children with type 1 diabetes using continuous glucose monitoring systems: A case control study;International Journal of Diabetes in Developing Countries;2024-01-19
5. Super Bolus—A Remedy for a High Glycemic Index Meal in Children with Type 1 Diabetes on Insulin Pump Therapy?—A Randomized, Double-Blind, Controlled Trial;Nutrients;2024-01-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3